Details for Patent: 9,526,738
✉ Email this page to a colleague
Which drugs does patent 9,526,738 protect, and when does it expire?
Patent 9,526,738 protects ZELSUVMI and is included in one NDA.
This patent has seven patent family members in five countries.
Summary for Patent: 9,526,738
Title: | Topical gels and methods of using the same |
Abstract: | Provided according to some embodiments of the invention are topical gels that may release nitric oxide. Also provided are methods of using such topical gels in the treatment of wounds and other skin ailments. The topical gels comprise diazeniutndiolate-functionalized polysiloxane macromolecules. |
Inventor(s): | Stasko Nathan, Bauman Susanne, Joshi Pranav R. |
Assignee: | Novan, Inc. |
Application Number: | US13256928 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 9,526,738
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lnhc | ZELSUVMI | berdazimer sodium | GEL;TOPICAL | 217424-001 | Jan 5, 2024 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,526,738
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Brazil | 112012003792 | ⤷ Try a Trial | |||
Canada | 2771308 | ⤷ Try a Trial | |||
Canada | 3062005 | ⤷ Try a Trial | |||
China | 102711729 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |